Most of the undesirable side effects of GCs such as central adiposity, dyslipidaemia, skeletal muscle wasting, osteoporosis, insulin resistance, glucose tolerance and diabetes have been attributed to the transactivation arm of GR [28]–[30]. The gene discussed is NR3C1; the disease is diabetes mellitus.